Who
Denise M. Faltischek
Chief Strategy Officer
Company insider
Files Form 4 as: Chief Strategy Officer, Tilray Brands; Director, Whole Earth Brands; EVP & Chief Strategy Officer, The Hain Celestial Group.
In numbers
- Trades disclosed
- 138
- Buys
- 3
- Sells
- 3
- Bought
- $85K
- Sold
- $950K
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 11 Mar 2010
- Last trade
- 26 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —58,204 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $151K30,849 at $4.88 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —120,017 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —58,204 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —120,017 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $310K63,610 at $4.88 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —58,204 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —120,017 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —58,204 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $151K30,849 at $4.88 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —120,017 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $310K63,610 at $4.88 | filing |
| 3 Aug 2026filed 4 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Bought | $12K2,500 at $4.78 | filing |
| 3 Aug 2026filed 4 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Bought | $12K2,500 at $4.78 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —26,120 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —26,120 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $58K13,844 at $4.20 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —26,120 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —26,120 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $58K13,844 at $4.20 | filing |
News
Head to Head Comparison: Cumberland Pharmaceuticals (NASDAQ:CPIX) versus Tilray Brands (NASDAQ:TLRY)TLRY · tickerreport.com · 24 Oct 2026Comparing Cumberland Pharmaceuticals (NASDAQ:CPIX) and Tilray Brands (NASDAQ:TLRY)TLRY · dailypolitical.com · 24 Oct 2026Analyzing Tilray Brands (NASDAQ:TLRY) and Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF)TLRY · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Denise M. Faltischek; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.